Galmed Pharmaceuticals Ltd.
EOCN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001595353
No open-market purchases or sales by Galmed Pharmaceuticals Ltd. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026
- 0
- 13F valueReported value at the end of Q2 2026
- $0
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding EOCN, Q2 2026
No superinvestor reported holding EOCN at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Galmed Pharmaceuticals Ltd. insiders from Form 4, newest first.
No open-market purchases or sales by Galmed Pharmaceuticals Ltd. insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Galmed Pharmaceuticals Ltd. at the end of Q2 2026; share changes are against Q1 2026.
No institution reported holding EOCN in 13F filings for Q2 2026.